Treatment of Acute Lymphoblastic Leukemia in Children and Adolescents: Peaks and Pitfalls
Open Access
- 1 January 2008
- journal article
- review article
- Published by American Society of Hematology in Hematology-American Society Hematology Education Program
- Vol. 2008 (1) , 374-380
- https://doi.org/10.1182/asheducation-2008.1.374
Abstract
Survival of children with acute lymphoblastic leukemia (ALL) is often described as the success story for oncology. The improvements in the treatment of ALL represent the work of cooperative groups at their best. Fifty years ago a pediatric oncologist would have never considered using the term “cure” in a discussion with a family whose child was diagnosed with ALL. Today the term is not only used in the initial discussion but referred to frequently thereafter. However, as we all know, cure is not assured and is not obtained without sequelae. This review will focus on the improvements in treatment for newly diagnosed ALL in children and adolescents according to risk group and some of the challenges that remain despite the improved outcome.Keywords
This publication has 38 references indexed in Scilit:
- Biology and Treatment of Acute Lymphoblastic LeukemiaPediatric Clinics of North America, 2008
- Childhood central nervous system leukemia: historical perspectives, current therapy, and acute neurological sequelaeNeuroradiology, 2007
- A treatment protocol for infants younger than 1 year with acute lymphoblastic leukaemia (Interfant-99): an observational study and a multicentre randomised trialThe Lancet, 2007
- Risk- and response-based classification of childhood B-precursor acute lymphoblastic leukemia: a combined analysis of prognostic markers from the Pediatric Oncology Group (POG) and Children's Cancer Group (CCG)Blood, 2006
- Analysis of prognostic factors of acute lymphoblastic leukemia in infants: report on CCG 1953 from the Children's Oncology GroupBlood, 2006
- Treatment of Acute Lymphoblastic LeukemiaNew England Journal of Medicine, 2006
- Biological and therapeutic aspects of infant leukemiaBlood, 2000
- Relation between age, immunophenotype and in vitro drug resistance in 395 children with acute lymphoblastic leukemia–implications for treatment of infantsLeukemia, 1998
- Early response to therapy and outcome in childhood acute lymphoblastic leukemiaCancer, 1997
- Uniform approach to risk classification and treatment assignment for children with acute lymphoblastic leukemia.Journal of Clinical Oncology, 1996